🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10402+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10402 recruiting trials

Phase 2RecruitingNCT05485155

Zemaira Eosinophilic Esophagitis Pilot Study

👨‍⚕️ Marc Rothenberg, Cincinnati Children's Hospital Medical Center📍 2 sites📅 Started May 2025View details ↗
Enrolling by InvitationNCT06717932

A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

🏥 CorrectSequence Therapeutics Co., Ltd📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT06771219

SLV-154 Treatment of Metastatic Solid Tumors

🏥 Solve Therapeutics📍 9 sites📅 Started May 2025View details ↗
NARecruitingNCT06968962

Comparison of Sequential to Initial Combination Therapy in PAH

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06798012

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

👨‍⚕️ Study Director, Takeda📍 20 sites📅 Started May 2025View details ↗
Phase 1RecruitingNCT06858397

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

👨‍⚕️ GC Biopharma📍 10 sites📅 Started May 2025View details ↗
RecruitingNCT07008820

Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

👨‍⚕️ Bristol Myers Squibb, Bristol-Myers Squibb📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06756230

Downhill Walking in IPF

🏥 Saglik Bilimleri Universitesi📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT06703606

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 4 sites📅 Started May 2025View details ↗
NARecruitingNCT06660082

Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit

🏥 Hospices Civils de Lyon📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT06961266

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

👨‍⚕️ Global Medical Lead, Jazz Pharmaceuticals📍 4 sites📅 Started May 2025View details ↗
Phase 4RecruitingNCT06803524

10-year Follow-up After a Single Dose Acellular Pertussis Vaccination

👨‍⚕️ Punnee Pitisuttithum, Vaccine trial Centre📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06921733

Ultrasound Localization Microscopy in Patient With Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

🏥 University of Erlangen-Nürnberg Medical School📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT07287514

Metabolic Effects of Linoleic Acid-Rich Oil Compared to a Blend Oil in Adults With Insulin Resistance

👨‍⚕️ Loni Berkowitz, PhD, Pontificia Universidad Catolica de Chile📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT06736379

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

👨‍⚕️ Fred M Baik, MD, Stanford University📍 1 site📅 Started May 2025View details ↗
Phase 3RecruitingNCT06923592

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

👨‍⚕️ Chris Drakeley, London School of Hygiene and Tropical Medicine📍 2 sites📅 Started May 2025View details ↗
Phase 3RecruitingNCT06563895

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

🏥 Eidos Therapeutics, a BridgeBio company📍 98 sites📅 Started May 2025View details ↗
Phase 4RecruitingNCT06668389

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

👨‍⚕️ Chun-Ka Dr Wong, Clinical Assistant Professor, The University of Hong Kong/ Department of Medicine, Queen Mary Hospital📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06644534

A Study to Assess TTI-0102 vs Placebo in MELAS Patients

👨‍⚕️ Patrice P Rioux, MD, PhD, Thiogenesis Therapeutics, Inc.📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06503367

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

👨‍⚕️ Anne M Connolly, MD, Nationwide Childrens Hospital📍 14 sites📅 Started May 2025View details ↗
← PreviousPage 111 of 521Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →